Cannabis Science Inc (CBIS) 0.0149 $CBIS
Cannabis Science and the Research Foundation Begins Protocols for California Legal Patients to Receive the New CBIS MDI Rescue Inhaler for Its First Observational Study Intending to Lead Into Clinical Trials
Marketwired - Fri Aug 12, 10:47AM CDT
IRVINE, CA--(Marketwired - Aug 12, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is happy to announce the intent to seek out 20 - 25 potential candidates suffering from Asthma/COPD and other critical ailments. These initial patients will receive the New MDI Inhalation device FREE for monitoring usage habits, combination levels, and tracking medical results. The observational study is being designed to accumulate valuable data to lead into clinical trials in the State of California.
Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables
Marketwire Canada - Thu Aug 11, 12:16PM CDT
IRVINE, CA--(Marketwired - Aug 11, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis based medicines, is happy to announce their first batch order for the previously announced cannabinoid based inhalation medicine for Asthma/COPD has been placed. It is expected to be received by the company within a week and released initially in select California dispensaries and available for delivery. The CBIS MDI Rescue Inhaler dosage is targeting 100 - 200 dose MDI with cannabinoid level variations ranging from 10mg, 25mg, up to 100mg THC, CBD, and other cannabinoid variables as patient/consumer analysis moves further down the road.
Production of Industrial Hemp to Dramatically Increase as Demand for Eco-Friendly Natural Fiber Continues to Rise
PR Newswire - Wed Aug 10, 7:45AM CDT
Industrial hemp known as a hardy and renewable resource (one of the earliest domesticated plants known) is quickly becoming a required resource for various industrial applications, including paper, textiles, and cordage. Sustainable hemp seed, fiber and oil are being used in raw materials by major companies, including Ford Motors, Patagonia, and The Body Shop, to make a wide variety of products as a few select Hemp manufacturers race to increase operations as the demand continues to grow.
XXII: 0.97 (+0.03)
Twenty Acre Indoor/Outdoor Cultivation Facility in Northern California in the Final Stages of Escrow Awaiting Transfer of Ownership to Cannabis Science, Inc.
Marketwired - Mon Aug 01, 12:09PM CDT
CBIS Prepares to Launch Indoor/Outdoor Cultivation for Genetics Targeting Critical Ailments and Patent Pending Drug Development Projects
Cannabis Science Develops Inhalation Medication for Those Suffering Asthma/COPD via Nebulizer, Targets National Markets
Marketwired - Fri Jul 29, 1:22PM CDT
IRVINE, CA--(Marketwired - Jul 29, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce they will release an inhalation medication for those suffering asthma/COPD for use in patient nebulizers. This product will be offered in states where marijuana is legal on a national basis.
Cannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles; Coined, "Cannabis Kills Cancer," a Celebratory Fund Raiser
Marketwire Canada - Thu Jun 16, 7:12AM CDT
LOS ANGELES, CA--(Marketwired - Jun 16, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, partners with FHP.TV & Kush Boys Studios to host its "black tie, red carpet" event in Los Angeles. Company officials state the gala is a celebratory fund raising event, coined "Cannabis Kills Cancer."
Cannabis Science to Host Black Tie, Red Carpet Event in Los Angeles: "Cannabis Kills Cancer," a Celebratory Fundraiser Dinner Event for Celebrities, Scientists, Doctors, Patients, and Loyalty Shareholders Alike
Marketwire Canada - Fri Jun 10, 11:19AM CDT
COLORADO SPRINGS, CO--(Marketwired - Jun 10, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, to host "black tie, red carpet" event in Los Angeles. Company officials state the gala is a celebratory fundraising event, "Cannabis Kills Cancer." Celebrities and Shareholders alike will join in on this unparalleled occasion to raise money for targeted cancer treatments using cannabinoids and unprecedented drug development expansions.
CBIS Delegation Completes Successful Trip to South Africa and Namibia and Launches Historic African Healthcare Initiative Led by Co-Founder, Mr. Raymond C. Dabney
Marketwire Canada - Tue Jun 07, 11:43AM CDT
WASHINGTON, DC--(Marketwired - Jun 7, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces the CBIS African healthcare infrastructure delegation led by Mr. Raymond Dabney and including Dr. Julius Garvey, member of the Scientific Advisory Board of CBIS, Dr. Allen Herman, Chief Medical Officer of CBIS, and Mr. Melvin Foote, President & CEO of Constituency for Africa has just concluded with outstanding results. The delegation has met the prime objectives of the trip to South Africa and is now planning the next steps and trip for a follow up implementation program.
CBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant Beverage, Canna POW!
Marketwire Canada - Thu Jun 02, 10:01AM CDT
NEUNKIRCHEN-RICHELBACH, GERMANY--(Marketwired - Jun 2, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced Cannabis Science Europe GmbH, a European subsidiary of Cannabis Science Inc., based in Germany, released the newest innovative product line: Canna POW! The first worldwide, premium quality, water soluble Cannabis Instant Beverage: Canna POW! Is starting distribution June 1, 2016, in Europe and Internationally.
CBIS African Delegation Arrives in Johannesburg, South Africa After Successful Cape Town Meetings With South African Parliament Members, University Cannabis Research Specialists, and Tour of NIH Equivalent, South African Medical Research Council (MRC)
Marketwired - Wed May 25, 8:44AM CDT
JOHANNESBURG, SOUTH AFRICA--(Marketwired - May 25, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines -- The CBIS delegation led by Mr. Raymond C. Dabney has arrived in Johannesburg, South Africa after a series of successful meetings and in-depth discussions in Cape Town, South Africa with South African Parliament members, key University cannabis research specialists, private industry front-runners, topped off with a tour and meetings with key executives at the South African Medical Research Council (MRC) which is the NIH equivalent research organization in South Africa.
Cannabis Science and the Research Foundation Begins Protocols for California Legal Patients to Receive the New CBIS MDI Rescue Inhaler for Its First Observational Study Intending to Lead Into Clinical Trials
Marketwired - Fri Aug 12, 10:47AM CDT
IRVINE, CA--(Marketwired - Aug 12, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is happy to announce the intent to seek out 20 - 25 potential candidates suffering from Asthma/COPD and other critical ailments. These initial patients will receive the New MDI Inhalation device FREE for monitoring usage habits, combination levels, and tracking medical results. The observational study is being designed to accumulate valuable data to lead into clinical trials in the State of California.
Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables
Marketwire Canada - Thu Aug 11, 12:16PM CDT
IRVINE, CA--(Marketwired - Aug 11, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis based medicines, is happy to announce their first batch order for the previously announced cannabinoid based inhalation medicine for Asthma/COPD has been placed. It is expected to be received by the company within a week and released initially in select California dispensaries and available for delivery. The CBIS MDI Rescue Inhaler dosage is targeting 100 - 200 dose MDI with cannabinoid level variations ranging from 10mg, 25mg, up to 100mg THC, CBD, and other cannabinoid variables as patient/consumer analysis moves further down the road.
Production of Industrial Hemp to Dramatically Increase as Demand for Eco-Friendly Natural Fiber Continues to Rise
PR Newswire - Wed Aug 10, 7:45AM CDT
Industrial hemp known as a hardy and renewable resource (one of the earliest domesticated plants known) is quickly becoming a required resource for various industrial applications, including paper, textiles, and cordage. Sustainable hemp seed, fiber and oil are being used in raw materials by major companies, including Ford Motors, Patagonia, and The Body Shop, to make a wide variety of products as a few select Hemp manufacturers race to increase operations as the demand continues to grow.
XXII: 0.97 (+0.03)
Twenty Acre Indoor/Outdoor Cultivation Facility in Northern California in the Final Stages of Escrow Awaiting Transfer of Ownership to Cannabis Science, Inc.
Marketwired - Mon Aug 01, 12:09PM CDT
CBIS Prepares to Launch Indoor/Outdoor Cultivation for Genetics Targeting Critical Ailments and Patent Pending Drug Development Projects
Cannabis Science Develops Inhalation Medication for Those Suffering Asthma/COPD via Nebulizer, Targets National Markets
Marketwired - Fri Jul 29, 1:22PM CDT
IRVINE, CA--(Marketwired - Jul 29, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce they will release an inhalation medication for those suffering asthma/COPD for use in patient nebulizers. This product will be offered in states where marijuana is legal on a national basis.
Cannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles; Coined, "Cannabis Kills Cancer," a Celebratory Fund Raiser
Marketwire Canada - Thu Jun 16, 7:12AM CDT
LOS ANGELES, CA--(Marketwired - Jun 16, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, partners with FHP.TV & Kush Boys Studios to host its "black tie, red carpet" event in Los Angeles. Company officials state the gala is a celebratory fund raising event, coined "Cannabis Kills Cancer."
Cannabis Science to Host Black Tie, Red Carpet Event in Los Angeles: "Cannabis Kills Cancer," a Celebratory Fundraiser Dinner Event for Celebrities, Scientists, Doctors, Patients, and Loyalty Shareholders Alike
Marketwire Canada - Fri Jun 10, 11:19AM CDT
COLORADO SPRINGS, CO--(Marketwired - Jun 10, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, to host "black tie, red carpet" event in Los Angeles. Company officials state the gala is a celebratory fundraising event, "Cannabis Kills Cancer." Celebrities and Shareholders alike will join in on this unparalleled occasion to raise money for targeted cancer treatments using cannabinoids and unprecedented drug development expansions.
CBIS Delegation Completes Successful Trip to South Africa and Namibia and Launches Historic African Healthcare Initiative Led by Co-Founder, Mr. Raymond C. Dabney
Marketwire Canada - Tue Jun 07, 11:43AM CDT
WASHINGTON, DC--(Marketwired - Jun 7, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces the CBIS African healthcare infrastructure delegation led by Mr. Raymond Dabney and including Dr. Julius Garvey, member of the Scientific Advisory Board of CBIS, Dr. Allen Herman, Chief Medical Officer of CBIS, and Mr. Melvin Foote, President & CEO of Constituency for Africa has just concluded with outstanding results. The delegation has met the prime objectives of the trip to South Africa and is now planning the next steps and trip for a follow up implementation program.
CBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant Beverage, Canna POW!
Marketwire Canada - Thu Jun 02, 10:01AM CDT
NEUNKIRCHEN-RICHELBACH, GERMANY--(Marketwired - Jun 2, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced Cannabis Science Europe GmbH, a European subsidiary of Cannabis Science Inc., based in Germany, released the newest innovative product line: Canna POW! The first worldwide, premium quality, water soluble Cannabis Instant Beverage: Canna POW! Is starting distribution June 1, 2016, in Europe and Internationally.
CBIS African Delegation Arrives in Johannesburg, South Africa After Successful Cape Town Meetings With South African Parliament Members, University Cannabis Research Specialists, and Tour of NIH Equivalent, South African Medical Research Council (MRC)
Marketwired - Wed May 25, 8:44AM CDT
JOHANNESBURG, SOUTH AFRICA--(Marketwired - May 25, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines -- The CBIS delegation led by Mr. Raymond C. Dabney has arrived in Johannesburg, South Africa after a series of successful meetings and in-depth discussions in Cape Town, South Africa with South African Parliament members, key University cannabis research specialists, private industry front-runners, topped off with a tour and meetings with key executives at the South African Medical Research Council (MRC) which is the NIH equivalent research organization in South Africa.
